Verschuuren JJGM - Search Results

1

The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.

van Coevorden-Hameete MH, de Bruijn MAAM, de Graaff E, Bastiaansen DAEM, Schreurs MWJ, Demmers JAA, Ramberger M, Hulsenboom ESP, Nagtzaam MMP, Boukhrissi S, Veldink JH, Verschuuren JJGM, Hoogenraad CC, Sillevis Smitt PAE, Titulaer MJ. van Coevorden-Hameete MH, et al. Among authors: verschuuren jjgm. Brain. 2019 Jun 1;142(6):1631-1643. doi: 10.1093/brain/awz094. Brain. 2019. PMID: 31009048 Free PMC article.

2

Hu antigens and anti-Hu antibodies in a patient with myxoid chondrosarcoma.

Verschuuren J, Twijnstra A, De Baets M, Thunnissen F, Dalmau J, van Breda Vriesman P. Verschuuren J, et al. Neurology. 1994 Aug;44(8):1551-2. doi: 10.1212/wnl.44.8.1551. Neurology. 1994. PMID: 8058170 No abstract available.

3

Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome.

Verschuuren JJ, Dalmau J, Tunkel R, Lang B, Graus F, Schramm L, Posner JB, Newsom-Davis J, Rosenfeld MR. Verschuuren JJ, et al. Neurology. 1998 Feb;50(2):475-9. doi: 10.1212/wnl.50.2.475. Neurology. 1998. PMID: 9484375

4

Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer.

Verschuuren JJ, Perquin M, ten Velde G, De Baets M, Vriesman PB, Twijnstra A. Verschuuren JJ, et al. J Neurol Neurosurg Psychiatry. 1999 Sep;67(3):353-7. doi: 10.1136/jnnp.67.3.353. J Neurol Neurosurg Psychiatry. 1999. PMID: 10449558 Free PMC article.

5

Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma.

Wirtz PW, Sillevis Smitt PA, Hoff JI, de Leeuw B, Lammers GJ, van Duinen SG, Verschuuren JJ. Wirtz PW, et al. J Neurol. 2002 Dec;249(12):1710-2. doi: 10.1007/s00415-002-0913-z. J Neurol. 2002. PMID: 12529794

6

Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis.

Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J, Lammers GJ. Overeem S, et al. Neurology. 2004 Jan 13;62(1):138-40. doi: 10.1212/01.wnl.0000101718.92619.67. Neurology. 2004. PMID: 14718718 Free PMC article.

7

Available treatment options for the management of Lambert-Eaton myasthenic syndrome.

Verschuuren JJ, Wirtz PW, Titulaer MJ, Willems LN, van Gerven J. Verschuuren JJ, et al. Expert Opin Pharmacother. 2006 Jul;7(10):1323-36. doi: 10.1517/14656566.7.10.1323. Expert Opin Pharmacother. 2006. PMID: 16805718 Review.

8

Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.

Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, Hart IK, Honnorat J, Sillevis Smitt PA, Verschuuren JJ, Voltz R; Paraneoplastic Neurological Syndrome Euronetwork. Vedeler CA, et al. Eur J Neurol. 2006 Jul;13(7):682-90. doi: 10.1111/j.1468-1331.2006.01266.x. Eur J Neurol. 2006. PMID: 16834698

9

SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.

Sabater L, Titulaer M, Saiz A, Verschuuren J, Güre AO, Graus F. Sabater L, et al. Neurology. 2008 Mar 18;70(12):924-8. doi: 10.1212/01.wnl.0000281663.81079.24. Epub 2007 Nov 21. Neurology. 2008. PMID: 18032743

10

Re: Lambert-Eaton myasthenic syndrome with pure ocular weakness.

Titulaer MJ, Wirtz PW, Wintzen AR, Verschuuren JJ. Titulaer MJ, et al. Neurology. 2008 Jan 1;70(1):86; author reply 86-7. doi: 10.1212/01.wnl.0000295708.62369.59. Neurology. 2008. PMID: 18166715 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page